Business was booming for Swiss pharma giant Novartis in the second quarter of 2025 with 11% net sales growth riding strong ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...

BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Qatar’s health care sector has undergone a profound transformation over the past decade, evolving into one of the most advanced systems in the GCC. Underpinned by Qatar National Vision (QNV) 2030, the ...

The global cancer gene therapy market size was US$ 1.5 billion in 2021. The global cancer gene therapy market is expected to grow to US$ 3.1 billion by 2030 by registering a compound annual growth ...

The global topical drug delivery market size was US$ 186.5 billion in 2021. The global topical drug delivery market size is forecast to reach US$ 385.4 billion by 2030, growing at a compound annual ...

ICRC Annual Report 2024 As humanitarian needs continued to grow, the ICRC remained steadfast in urging compliance with international humanitarian law and providing assistance where people needed it ...

The Human Rights Commission’s 2024 Annual Report has been released. A spokesperson said, “The Human Rights Commission’s 2024 Annual Report was laid in the House of Assembly today, July 18 ...